Cellect Biotechnology (APOP) Prices IPO at $6.50/ADS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Cellect Biotechnology Ltd. Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing
July 29, 2016 8:47 AM EDTKFAR SABA, Israel, July 29, 2016 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: APOP) (NASDAQ: APOPW) (TASE:CLBD), a developer of innovative technology which enables the functional selection of stem cells, today announced the pricing of its initial public offering in the United States of 1,292,308 American Depository Shares (ADSs) and warrants to purchase up to 969,231 ADSs. Each ADS, representing 20 ordinary shares of the Company, and each warrant to purchase ADSs (in an amount equal to 75% of the ADSs purchased)Â are offered at a combined price to the public of $6.50.... More
